Evidence map›Paper›PMID 34660544›Full record

ReviewFrontiers in bioengineering and biotechnology2021

Critical Capability Needs for Reduction of Transmission of SARS-CoV-2 Indoors.

Jayne B Morrow, Aaron I Packman, Kenneth F Martinez, Kevin Van Den Wymelenberg, Darla Goeres, Delphine K Farmer, Jade Mitchell, Lisa Ng, Yair Hazi, Monica Schoch-Spana and 3 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jayne B MorrowCenter for Biofilm Engineering, Montana State University, Bozeman, MT, United States.
Aaron I PackmanDepartment of Civil and Environmental Engineering, Northwestern University, Evanston, IL, United States.
Kenneth F MartinezIntegrated Bioscience and Built Environment Consortium (IBEC), Sanford, FL, United States.
Kevin Van Den WymelenbergBiology and the Built Environment Center, College of Design, Institute for Health in the Built Environment, University of Oregon, Eugene, OR, United States.
Darla GoeresCenter for Biofilm Engineering, Montana State University, Bozeman, MT, United States.
Delphine K FarmerDepartment of Chemistry, Colorado State University, Fort Collins, CO, United States.
Jade MitchellDepartment of Biosystems Engineering, Michigan State University, East Lansing, MI, United States.
Lisa NgEngineering Laboratory, National Institute of Standards and Technology, Gaithersburg, MD, United States.
Yair HaziHWC Inc., Washington, DC, United States.
Monica Schoch-SpanaJohns Hopkins Center for Health Security, John Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States.
Sandra QuinnDepartment of Family Science and Center for Health Equity, School of Public Health, University of Maryland, College Park, MD, United States.
William BahnflethDepartment of Architectural Engineering, The Pennsylvania State University, University Park, PA, United States.
Paula OlsiewskiJohns Hopkins Center for Health Security, John Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coordination of efforts to assess the challenges and pain points felt by industries from around the globe working to reduce COVID-19 transmission in the indoor environment as well as innovative solutions applied to meet these challenges is mandatory. Indoor infectious viral disease transmission (such as coronavirus, norovirus, influenza) is a complex problem that needs better integration of our current knowledge and intervention strategies. Critical to providing a reduction in transmission is to map the four core technical areas of environmental microbiology, transmission science, building science, and social science. To that end a three-stage science and innovation Summit was held to gather information on current standards, policies and procedures applied to reduce transmission in built spaces, as well as the technical challenges, science needs, and research priorities. The Summit elucidated steps than can be taken to reduce transmission of SARS-CoV-2 indoors and calls for significant investments in research to enhance our knowledge of viral pathogen persistence and transport in the built environment, risk assessment and mitigation strategy such as processes and procedures to reduce the risk of exposure and infection through building systems operations, biosurveillance capacity, communication form leadership, and stakeholder engagement for optimal response. These findings reflect the effective application of existing knowledge and standards, emerging science, and lessons-learned from current efforts to confront SARS-CoV-2.

Indexed as

biosurveillancebuildingsCOVID-19human factorsindoorsrisk reduction and mitigation measuresSARS-CoV-2transmission

Identifiers

PMID34660544
PMCPMC8513777

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.